Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of a tamsulosin/solifenacin combination for voiding and storage symptoms in men with benign prostatic hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin (solifenacin)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Benign Prostate Hyperplasia | Phase 3 | Status: UNKNOWN